Carmat (France) Performance
| ALCAR Stock | EUR 0.97 0.03 3.00% |
The firm shows a Beta (market volatility) of -0.2, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Carmat are expected to decrease at a much lower rate. During the bear market, Carmat is likely to outperform the market. At this point, Carmat has a negative expected return of -0.69%. Please make sure to confirm Carmat's potential upside, as well as the relationship between the daily balance of power and market facilitation index , to decide if Carmat performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Carmat has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors. ...more
| Begin Period Cash Flow | 36 M | |
| Total Cashflows From Investing Activities | -1.8 M | |
| Free Cash Flow | -61.9 M |
Carmat |
Carmat Relative Risk vs. Return Landscape
If you would invest 167.00 in Carmat on September 24, 2024 and sell it today you would lose (70.00) from holding Carmat or give up 41.92% of portfolio value over 90 days. Carmat is generating negative expected returns and assumes 5.1652% volatility on return distribution over the 90 days horizon. Simply put, 45% of stocks are less volatile than Carmat, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Carmat Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Carmat's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Carmat, and traders can use it to determine the average amount a Carmat's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1341
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ALCAR |
Estimated Market Risk
| 5.17 actual daily | 46 54% of assets are more volatile |
Expected Return
| -0.69 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.13 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Carmat is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Carmat by adding Carmat to a well-diversified portfolio.
Carmat Fundamentals Growth
Carmat Stock prices reflect investors' perceptions of the future prospects and financial health of Carmat, and Carmat fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Carmat Stock performance.
| Return On Equity | -2.54 | |||
| Return On Asset | -0.39 | |||
| Operating Margin | (21.94) % | |||
| Current Valuation | 218.78 M | |||
| Shares Outstanding | 22.67 M | |||
| Price To Earning | (6.35) X | |||
| Price To Book | 1,235 X | |||
| Price To Sales | 87.71 X | |||
| Revenue | 2.34 M | |||
| EBITDA | (51.98 M) | |||
| Cash And Equivalents | 25.3 M | |||
| Cash Per Share | 2.73 X | |||
| Total Debt | 52.02 M | |||
| Debt To Equity | 22.60 % | |||
| Book Value Per Share | 0.06 X | |||
| Cash Flow From Operations | (60.17 M) | |||
| Earnings Per Share | (3.54) X | |||
| Total Asset | 69.08 M | |||
| Retained Earnings | (94 M) | |||
| Current Asset | 7 M | |||
| Current Liabilities | 5 M | |||
About Carmat Performance
Assessing Carmat's fundamental ratios provides investors with valuable insights into Carmat's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Carmat is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
Carmat SA designs and develops total artificial heart for people suffering from end-stage biventricular heart failure in France and internationally. The company was founded in 2008 and is based in Vlizy-Villacoublay, France. CARMAT operates under Medical Instruments Supplies classification in France and is traded on Paris Stock Exchange. It employs 81 people.Things to note about Carmat performance evaluation
Checking the ongoing alerts about Carmat for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Carmat help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Carmat generated a negative expected return over the last 90 days | |
| Carmat has high historical volatility and very poor performance | |
| Carmat has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 2.34 M. Net Loss for the year was (61.87 M) with loss before overhead, payroll, taxes, and interest of (37.45 M). | |
| Carmat has accumulated about 25.3 M in cash with (60.17 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.73, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 43.0% of the company shares are held by company insiders |
- Analyzing Carmat's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Carmat's stock is overvalued or undervalued compared to its peers.
- Examining Carmat's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Carmat's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Carmat's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Carmat's stock. These opinions can provide insight into Carmat's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Carmat Stock Analysis
When running Carmat's price analysis, check to measure Carmat's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carmat is operating at the current time. Most of Carmat's value examination focuses on studying past and present price action to predict the probability of Carmat's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carmat's price. Additionally, you may evaluate how the addition of Carmat to your portfolios can decrease your overall portfolio volatility.